Clear Street’s LAVA Medtech Acquisition Corp. Unit LVACU Stock Holding History

Clear Street’s Portfolio LVACU Stock Details LVACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,150	Closed	-$12K	–	1634
2023 Q1	$12K	Buy	+1,150	New	+$11.9K	﹤0.01%	470
2022 Q3	–	Sell	-5,827	Closed	-$58K	–	1567
2022 Q2	$58K	Buy	5,827 +937	+19%	+$9.42K	﹤0.01%	227
2022 Q1	$49K	Sell	4,890 -3,276	-40%	-$33.1K	0.01%	138
2021 Q4	$82K	Buy	+8,166	New	+$82.6K	﹤0.01%	78

Clear Street's LVACU Position: Q2 2023 in Review

Clear Street sold out of LAVA Medtech Acquisition Corp. Unit (LVACU) in Q2 2023, closing a stake of 1,150 shares — an estimated $12K sold.

Clear Street first reported a position in LVACU in Q4 2021 and held it in 4 quarters. The position peaked at $82K in Q4 2021. 0 funds tracked by Wall St. Rank hold LVACU as of Q2 2023.

Clear Street reported no remaining LAVA Medtech Acquisition Corp. Unit position as of Q2 2023 after selling out during the quarter.
Clear Street sold 1,150 LAVA Medtech Acquisition Corp. Unit shares in Q2 2023, an estimated $12K.
Clear Street first reported a position in LAVA Medtech Acquisition Corp. Unit in Q4 2021 and held it in 4 quarters.
Clear Street's LAVA Medtech Acquisition Corp. Unit position peaked at $82K in Q4 2021.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Unit as of Q2 2023.

Based on Clear Street's 13F filing for Q2 2023, filed 14 Aug 2023.